Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer
- 1 March 1999
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 67 (3), 790-797
- https://doi.org/10.1016/s0003-4975(98)01257-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Evaluation of the solitary pulmonary nodule by positron emission tomography imagingEuropean Respiratory Journal, 1996
- Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.American Journal of Respiratory and Critical Care Medicine, 1996
- Investigation for mediastinal disease in patients with apparently operable lung cancerThe Annals of Thoracic Surgery, 1995
- Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancerThe Lancet, 1994
- Preoperative screening for metastases in lung cancer.Thorax, 1994
- Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging.Thorax, 1992
- A New International Staging System for Lung CancerChest, 1986
- Mediastinal lymph node size in lung cancerAmerican Journal of Roentgenology, 1984